Team:Brown/Project/Strategy

Components of auto-lysis device

Inducible promoter

In order to test the efficacy of the “lysis cassette,” our team first took advantage of the well-characterized pBAD promoter. We obtained the lysis cassette from the Mekalanos lab at Harvard Medical School on the pBAD18 plasmid.

In the future, the team would like to test the ability of lead, mercury, arsenic, and xylene inducible promoters to induce the lysis cassette in the presence of the respective toxins.

Lysis cassette

The lysis cassette consists of the S,R, and Rz genes under the control of a single promoter. These genes occur naturally in the lytic bacteriophage in an overlapping cluster downstream of the promoter P’r and lead to a specifically timed lytic event in the phage’s infective cycle. In bacteriophages, both the S105 and the S107 proteins are created, the S107 protein being an “anti-holin” that disrupts the activity of the S105 protein, the “lethal lysis effector.” The S107 gene has been deleted from the gene cassette used in experimentation.

The S protein (S105 gene) is a holin protein that inserts an unspecific inner membrane channel (M[r]= 8,500) in the cell membrane of the bacteria. The S proteins accumulate within the cell and cause membrane lesions simultaneously some time after translation. The lesion halts respiration, enables small molecules to leave the cell, and causes the cell to die (not lyse), even in the absence of an endolysin protein.

The R gene (endolysin)encodes for a soluble transglycosylase. The S105 channels permeabilize the cell membrane to these proteins, allowing R proteins access to the periplasm. The protein attacks the peptidoglycan of the cell wall, inducing lysis.

The Rz gene encodes for a gene of unknown function and is not necessary for lysis in laboratory conditions unless the cell membrane is stabilized by high concentrations of divalent ions. (1)

Electrical Reporting

Conductance of the bacterial solution before and after lysis was measured to detect the change in ionic concentration of the extracellular solution.